The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of tunlametinib in combination with vemurafenib in patients with BRAF V600-mutant advanced melanoma.
 
Xiaoting Wei
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Zhengyun Zou
No Relationships to Disclose
 
Weizhen Zhang
No Relationships to Disclose
 
Meiyu Fang
No Relationships to Disclose
 
Wenbin Liu
Employment - Shanghai KeChow Pharma
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere
 
Lu Si
No Relationships to Disclose